Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ROM-K Inhibitors

ROM-K inhibitors belong to a chemical class that primarily targets the renal outer medullary potassium (ROM-K) channels. These channels are found in the kidneys and play a crucial role in the regulation of potassium balance. ROM-K inhibitors are designed to selectively block the activity of these channels, thereby altering the transport of potassium ions across the renal tubules. By modulating the movement of potassium, ROM-K inhibitors influence potassium excretion and reabsorption. The inhibition of ROM-K channels is believed to have a direct impact on the renal handling of potassium, which can have important physiological implications. Chemically, ROM-K inhibitors are characterized by their ability to bind to the ROM-K channels, preventing the normal flow of potassium ions through the channel pore. This binding interaction typically occurs at specific sites within the channel structure, leading to a conformational change that reduces the potassium conductance. This inhibition of ROM-K channels can result in increased urinary potassium excretion. The development and study of ROM-K inhibitors have been of interest to researchers due to their ability to influence potassium homeostasis. By selectively inhibiting ROM-K channels, these compounds offer a mechanism to modulate potassium reabsorption and excretion. This may be particularly relevant in situations where abnormal potassium levels are observed or in conditions characterized by potassium dysregulation. Overall, ROM-K inhibitors represent a chemical class that specifically targets the renal outer medullary potassium channels. Through their selective inhibition of these channels, ROM-K inhibitors affect potassium transport and homeostasis.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tertiapin LQ

sc-362807
1 mg
$175.00
(0)

Tertiapin LQ is a potent modulator of ion channel activity, exhibiting a unique affinity for specific receptor sites. Its structure allows for intricate hydrogen bonding and hydrophobic interactions, which stabilize its binding to target proteins. The compound demonstrates remarkable selectivity, influencing ion flow and cellular excitability. Additionally, its dynamic conformational changes during binding contribute to its distinct pharmacokinetic profile, impacting cellular signaling cascades.